IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy

By L. Ivashkiv. Nature reviews. Immunology, 2018

1,097 citations recorded by the source corpus.

Subfields: Immunology, Oncology

View Paper: https://www.semanticscholar.org/paper/c50017000075802822074a73f1c31520d3262835

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Y. Shiravand
2. R. Ladwa
3. K. O'Byrne
4. S. R. Hosseini-Fard
5. Faezeh Khodadadi
6. Seyyed Mohammad Amin Kashani
7. H. Sadeghirad
8. Shadi Hosseini

Citations in the corpus

• Immune Checkpoint Inhibitors in Cancer Therapy (2022, background): “However, IFN-γ can promote tumourigenesis by increasing the expression of indoleamine 2,3dioxygenase 1 (IDO1), CTLA-4, and PD-L1 [135,136].”